col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


161 Results       Page 1

 [1] 
Elsevier: International Journal of Biological Macromolecules
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―22 Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing Puja Jaishwal, Kisalay Jha, Satarudra Prakash Singh
2 [GO] 2024―Jul―20 Bioproduction and immunogenic evaluation of SARS-CoV-2 prototype vaccine in silkworm BmN cells Hao Zheng, Hengfeng Zhao, Haifan Xiong, Mian Muhammad Awais, Songrong Zeng, Jingchen Sun
3 [GO] 2024―Jul―11 Preparation and immunological activity evaluation of an intranasal protein subunit vaccine against ancestral and mutant SARS-CoV-2 with curdlan sulfate/O-linked quaternized chitosan nanoparticles as carrier and adjuvant Yipan Chen, Yan Wang, Zuyi Li, Honglei Jiang, Wei Pan, Minghui Liu, et al. (+3)
4 [GO] 2024―Jul―04 Lectins in oncology and virology: Mechanisms of anticancer activity and SARS-CoV-2 inhibition Iryna Boliukh, Agnieszka Rombel-Bryzek, Rafał J. Bułdak
5 [GO] 2024―Jul―02 SARS-CoV-2 inhibitory potential of fish oil-derived 2-pyrone compounds by acquiring linoleic acid binding site on the spike protein Nandkishor Duragkar, Rupesh Chikhale, Malgorzata Piechota, Chhanda Charan Danta, Pradeep Gandhale, Prakash Itankar, et al. (+7)
6 [GO] 2024―Jun―27 Influence of EGCG oxidation on inhibitory activity against the SARS-CoV-2 main protease Yufeng He, Meng Hao, Mingchuan Yang, Huimin Guo, Margaret P. Rayman, Xiangchun Zhang, Jinsong Zhang
7 [GO] 2024―Jun―15 Unveiling potential inhibitors targeting the nucleocapsid protein of SARS-CoV-2: Structural insights into their binding sites Shweta Kumari, Hiral Mistry, Subhash C. Bihani, Sulakshana P. Mukherjee, Gagan D. Gupta
8 [GO] 2024―Jun―10 Discovery of procyanidin condensed tannins of (-)-epicatechin from Kratom, Mitragyna speciosa, as virucidal agents against SARS-CoV-2 Sanya Sureram, Nopporn Chutiwitoonchai, Tam Pooprasert, Watchara Sangsopha, Suphitcha Limjiasahapong, Narumol Jariyasopit, et al. (+5)
9 [GO] 2024―Jun―03 Rapid production of COVID-19 subunit vaccine candidates and their immunogenicity evaluation in pigs Renhe Yan, Jun Liu, Zedian Chen, Pengfei Wan, Tiekun Liang, Kanhe Li, et al. (+7)
10 [GO] 2024―May―18 Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis Shaban Ahmad, Akash Pratap Singh, Nagmi Bano, Khalid Raza, Janmejay Singh, Guruprasad R. Medigeshi, et al. (+2)
11 [GO] 2024―May―15 Comparative study of the interactions between C60 fullerene and SARS-CoV-2, HIV, eukaryotic, and bacterial model membranes: Insights into antimicrobial strategies with C60-peptide hybrids Masoud Shahriari, Majid Jafari, Farahnoosh Doustdar, Faramarz Mehrnejad
12 [GO] 2024―May―10 Enhancing the understanding of SARS-CoV-2 protein with structure and detection methods: An integrative review Ruiqi Wang, Song Lu, Fanyu Deng, Liqing Wu, Guowu Yang, Siying Chong, Yahui Liu
13 [GO] 2024―May―10 The synthesis and preliminary immunological evaluation of a dual-adjuvant SARS-CoV-2 RBD vaccine: Covalent integration of TLR7/8 and iNKT cell agonists Ying Xu, Jing Yang, Xiongyan Meng, Shuai Meng, Tiantian Sun, Ning Ding, Chengli Zong
14 [GO] 2024―Apr―28 Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity Thalia Belmonte, Manel Perez-Pons, Iván D. Benítez, Marta Molinero, María C. García-Hidalgo, Carlos Rodríguez-Muñoz, et al. (+10)
15 [GO] 2024―Apr―26 Development and application of a blocking ELISA based on a N protein monoclonal antibody for the antibody detection against porcine reproductive and respiratory syndrome virus 2 Wansheng Li, Yanwei Li, Minhua Li, Hongliang Zhang, Zixuan Feng, Hu Xu, et al. (+7)
16 [GO] 2024―Apr―21 ORF3a of SARS-CoV-2 modulates PI3K/AKT signaling in human lung epithelial cells via hsa-miR-155-5p Faiyaz Ahmad, Vishal Keshri, Sunit K. Singh
17 [GO] 2024―Apr―04 SARS-CoV-2 Mpro oligomerization as a potential target for therapy Kinga Lis, Jacek Plewka, Filipe Menezes, Ewa Bielecka, Yuliya Chykunova, Katarzyna Pustelny, et al. (+7)
18 [GO] 2024―Apr―03 An unprecedented global challenge, emerging trends and innovations in the fight against COVID-19: A comprehensive review S. Moneshwaran, D. Macrin, N. Kanagathara
19 [GO] 2024―Mar―24 A comprehensive analysis of SARS-CoV-2 missense mutations indicates that all possible amino acid replacements in the viral proteins occurred within the first two-and-a-half years of the pandemic Nicole Balasco, Gianluca Damaggio, Luciana Esposito, Vincenza Colonna, Luigi Vitagliano
20 [GO] 2024―Mar―19 Identification of potential vaccine targets for elicitation of host immune cells against SARS-CoV-2 by reverse vaccinology approach Sabina Yasmin, Mohmmad Yousuf Ansari, Krishna Pandey, Manas Ranjan Dikhit
21 [GO] 2024―Mar―15 Antigenicity, epitope mapping, and intracellular distribution of the NSP7α protein of porcine reproductive and respiratory syndrome virus Tao Wang, Da-Song Xia, Xiao-Xiao Tian, Yong-Bo Yang, Tong-Qing An
22 [GO] 2024―Mar―12 Self-assembled ferritin-based nanoparticles elicit a robust broad-spectrum protective immune response against SARS-CoV-2 variants Weiqi Wang, Xianyong Meng, Huan Cui, Cheng Zhang, Shen Wang, Na Feng, et al. (+4)
23 [GO] 2024―Mar―11 Characterization of chitosan/Persian gum nanoparticles for encapsulation of Nigella sativa extract as an antiviral agent against avian coronavirus Mohammad Hadian, Morteza Fathi, Ali Mohammadi, Mohammad Hadi Eskandari, Mehdi Asadsangabi, Khadijeh Pouraghajan, et al. (+3)
24 [GO] 2024―Mar―08 An allosteric mechanism for potent inhibition of SARS-CoV-2 main proteinase Yunju Zhang, Jingjing Guo, Yang Liu, Yuanyuan Qu, Yong-Qiang Li, Yuguang Mu, Weifeng Li
25 [GO] 2024―Mar―07 pGM-CSF as an adjuvant in DNA vaccination against SARS-CoV-2 Chang Liu, Ruo-Yi Xue, Guo-Cheng Li, Yi Zhang, Wei-Yi Wu, Jing-Yi Liu, et al. (+8)
26 [GO] 2024―Feb―21 Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CLpro inhibitors Feng Wang, Donglan Liu, Dingding Gao, Jinwei Yuan, Jingxian Zhao, Shuai Yuan, et al. (+4)
27 [GO] 2024―Feb―12 Investigating vulnerability of the conserved SARS-CoV-2 spike's heptad repeat 2 as target for fusion inhibitors using chimeric miniproteins Daniel Polo-Megías, Mario Cano-Muñoz, Alberto G. Berruezo, Géraldine Laumond, Christiane Moog, Francisco Conejero-Lara
28 [GO] 2024―Feb―10 MD simulations indicate Omicron P132H of SARS-CoV-2 Mpro is a potential allosteric ymutant involved in modulating the dynamics of catalytic site entry loop Zahoor Ahmad Bhat, Mohd Muzammil Khan, Ayyub Rehman, Jawed Iqbal, B.S. Sanjeev, Arumugam Madhumalar
29 [GO] 2024―Feb―06 PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines Sara Feola, Jacopo Chiaro, Manlio Fusciello, Salvatore Russo, Iivari Kleino, Leena Ylösmäki, et al. (+22)
30 [GO] 2024―Jan―27 Inhibition of multiple SARS-CoV-2 variants entry by Lycium barbarum L. polysaccharides through disruption of spike protein-ACE2 interaction Jingxuan Li, Feng Liu, Fushan Wu, Xiaoyue Su, Lihui Zhang, Xueru Zhao, et al. (+5)
31 [GO] 2024―Jan―22 Identification of antiviral phytochemicals from cranberry as potential inhibitors of SARS-CoV-2 main protease (Mpro) U. Jisha Pillai, Lucy Cherian, Khushman Taunk, Eldhose Iype, Mainak Dutta
32 [GO] 2024―Jan―15 Overview of the SARS-CoV-2 nucleocapsid protein Ahmed Eltayeb, Faisal Al-Sarraj, Mona Alharbi, Raed Albiheyri, Ehab Mattar, Isam M. Abu Zeid, et al. (+5)
33 [GO] 2024―Jan―09 A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19 Daohong Zhang, Deepak Kukkar, Ki-Hyun Kim, Poornima Bhatt
34 [GO] 2023―Dec―28 Severe acute respiratory syndrome Coronavirus-2 GenoAnalyzer and mutagenic anomaly detector using FCMFI and NSCE Shivendra Dubey, Dinesh Kumar Verma, Mahesh Kumar
35 [GO] 2023―Dec―28 Structurally defined heparin octasaccharide domain for binding to SARS-CoV-2 Omicron BA.4/BA.5/BA.5.2 spike protein RBD Zizhe An, Changkai Bu, Deling Shi, Qingqing Chen, Bin Zhang, Qingchi Wang, et al. (+2)
36 [GO] 2023―Dec―22 Multivalent nanobody-based sandwich enzyme-linked immunosorbent assay for sensitive detection of porcine reproductive and respiratory syndrome virus Mingxia Sun, Yue Sun, Yongbo Yang, Man Zhao, Dan Cao, Minmin Zhang, et al. (+7)
37 [GO] 2023―Dec―17 Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2 Muhammad Waqas, Saeed Ullah, Sobia Ahsan Halim, Najeeb Ur Rehman, Amjad Ali, Afnan Jan, et al. (+3)
38 [GO] 2023―Dec―07 Danshensu inhibits SARS-CoV-2 by targeting its main protease as a specific covalent inhibitor and discovery of bifunctional compounds eliciting antiviral and anti-inflammatory activity Ruyu Wang, Xuwen Chen, Hongtao Li, Xixiang Chen, Donghui Sun, Danmei Yu, et al. (+8)
39 [GO] 2023―Nov―22 Structure-guided design of a trivalent nanobody cluster targeting SARS-CoV-2 spike protein Xinyi Jiang, Qin Qin, Haixia Zhu, Jiaqiang Qian, Qiang Huang
40 [GO] 2023―Nov―08 Lipid and cholesterols modulate the dynamics of SARS-CoV-2 viral ion channel ORF3a and its pathogenic variants Madhusmita Rout, Sarbani Mishra, Sunita Panda, Budheswar Dehury, Sanghamitra Pati
41 [GO] 2023―Oct―15 Dauricine interferes with SARS-CoV-2 variants infection by blocking the interface between RBD and ACE2 Lei Xie, Sai Shi, Lin Cheng, Binghong Xu, Sen Ma, Jie Liu, et al. (+3)
42 [GO] 2023―Oct―13 Discovery of druggable potent inhibitors of serine proteases and farnesoid X receptor by ligand-based virtual screening to obstruct SARS-CoV-2 Sumera Zaib, Nehal Rana, Hafiz Saqib Ali, Nadia Hussain, Hanan A. Ogaly, Fatimah A.M. Al-Zahrani, Imtiaz Khan
43 [GO] 2023―Oct―09 Codon usage bias analysis of the spike protein of human coronavirus 229E and its host adaptability Meng Lu, Wenbo Wan, Yuxing Li, Haipeng Li, Bowen Sun, Kang Yu, et al. (+3)
44 [GO] 2023―Sep―29 A SARS-CoV-2 nanoparticle vaccine based on chemical conjugation of loxoribine and SpyCatcher/SpyTag Wenying Yan, Weili Yu, Lijuan Shen, Lucheng Xiao, Jinming Qi, Tao Hu
45 [GO] 2023―Sep―27 Assessing the interaction between hemoglobin and the receptor binding domain of SARS-CoV-2 spike protein through MARTINI coarse-grained molecular dynamics Jessica Gasparello, Marco Verona, Adriana Chilin, Roberto Gambari, Giovanni Marzaro
46 [GO] 2023―Sep―12 Effects of the glycosylation of the receptor binding domain (RBD dimer)-based Covid-19 vaccine (ZF2001) on its humoral immunogenicity and immunoreactivity Xueqing Wang, Lulu Shi, Yirong Wang, Jia Chen, Zelan Yang, Chenglong Liu, et al. (+6)
47 [GO] 2023―Sep―09 An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and its' most variants Weihong Zeng, Xiaoying Jia, Xiangyang Chi, Xinghai Zhang, Entao Li, Yan Wu, et al. (+9)
48 [GO] 2023―Aug―02 Mutation and codon bias analysis of the spike protein of omicron, the recent variant of SARS-COV-2 Yunbiao Lu, Weixiu Wang, Hao Liu, Yue Li, Yan Ge, Giovanni Franzo, et al. (+2)
49 [GO] 2023―Jul―26 Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants Lidong Wang, Yang Wang, Hao Zhou
50 [GO] 2023―Jul―23 Deciphering the role of fucoidan from brown macroalgae in inhibiting SARS-CoV-2 by targeting its main protease and receptor binding domain: Invitro and insilico approach Nidhi Hans, Shreya Gupta, Ashok Kumar Patel, Satyanarayan Naik, Anushree Malik
51 [GO] 2023―Jul―10 Three-dimensional porous wood monolithic columns for efficient purification of spike glycoprotein of SARS-CoV-2 Yuting Ren, Peng Ye, Limei Zhang, Jingyang Zhao, Jing Liu, Jiandu Lei, Luying Wang
52 [GO] 2023―Jul―07 Synthesis of multivalent sialyllactose-conjugated PAMAM dendrimers: Binding to SARS-CoV-2 spike protein and influenza hemagglutinin Peng He, Ke Xia, Yuefan Song, Ritesh Tandon, Rudra Channappanavar, Fuming Zhang, Robert J. Linhardt
53 [GO] 2023―Jul―03 Synthesis and characterization of n-phosphonium chitosan and its virucidal activity evaluation against coronavirus Celso Fidelis de Moura Junior, Deise Ochi, Emanuelle Dantas Freitas, Jonas Kerwald, Marcos Akira d'Ávila, Marisa Masumi Beppu
54 [GO] 2023―Jun―24 Inhibitory effect of lactoferrin-coated zinc nanoparticles on SARS-CoV-2 replication and entry along with improvement of lung fibrosis induced in adult male albino rats Esmail M. El-Fakharany, Hamada El-Gendi, Yousra A. El-Maradny, Marwa M. Abu-Serie, Khaled G. Abdel-Wahhab, Marwa E. Shaban, Mahmoud Ashry
55 [GO] 2023―Jun―07 Eco-friendly and effective antimicrobial Melaleuca alternifolia essential oil Pickering emulsions stabilized with cellulose nanofibrils against bacteria and SARS-CoV-2 Greiciele da S. Ferreira, Daniel J. da Silva, Alana G. Souza, Eliana D.C. Yudice, Ivana B. de Campos, Rute Dal Col, et al. (+3)
56 [GO] 2023―Jun―03 Identification and characterization of 7-azaindole derivatives as inhibitors of the SARS-CoV-2 spike-hACE2 protein interaction Chaojie Wang, Fengming He, Ke Sun, Kaiqiang Guo, Sheng Lu, Tong Wu, et al. (+2)
57 [GO] 2023―Jun―01 How helpful were molecular dynamics simulations in shaping our understanding of SARS-CoV-2 spike protein dynamics? Jameel M. Abduljalil, Ahmed M. Elghareib, Ahmed Samir, Ahmed A. Ezat, Abdo A. Elfiky
58 [GO] 2023―May―17 A novel mutation-proof, next-generation vaccine to fight against upcoming SARS-CoV-2 variants and subvariants, designed through AI enabled approaches and tools, along with the machine learning based immune simulation: A vaccine breakthrough Manojit Bhattacharya, Abdulrahman Alshammari, Metab Alharbi, Kuldeep Dhama, Sang-Soo Lee, Chiranjib Chakraborty
59 [GO] 2023―May―11 Development of 2-chloroquinoline based heterocyclic frameworks as dual inhibitors of SARS-CoV-2 MPro and PLPro Bhavita Kattula, Bharati Reddi, Aruna Jangam, Lekhika Naik, Bala Manikanta Adimoolam, Suresh Vavilapalli, et al. (+5)
60 [GO] 2023―Apr―28 GMI, a fungal immunomodulatory protein, ameliorates SARS-CoV-2 envelope protein-induced inflammation in macrophages via inhibition of MAPK pathway Zhi-Hu Lin, Hsin Yeh, Hung-Chih Lo, Wei-Jyun Hua, Ming-Yang Ni, Li-Kai Wang, et al. (+3)
61 [GO] 2023―Apr―11 Molecular insights into the inhibition mechanism of harringtonine against essential proteins associated with SARS-CoV-2 entry Zhiwei Yang, Xinyue Fu, Yizhen Zhao, Xuhua Li, Jiangang Long, Lei Zhang
62 [GO] 2023―Mar―29 Preparation of a new monoclonal antibody against nucleocapsid protein of swine acute diarrhea syndrome coronavirus and identification of its linear antigenic epitope Xiao Cong, Lin Zhang, Haibo Zhu, Miaoli Wu, Yujun Zhu, Yuexiao Lian, et al. (+3)
63 [GO] 2023―Mar―28 Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches Hafiz Muzzammel Rehman, Muhammad Sajjad, Muhammad Akhtar Ali, Roquyya Gul, Muhammad Naveed, Muhammad Shahbaz Aslam, et al. (+7)
64 [GO] 2023―Mar―10 Protein-based nano-vaccines against SARS-CoV-2: Current design strategies and advances of candidate vaccines Dongliang Wang, Youqing Yuan, Bin Liu, Neal D. Epstein, Yi Yang
65 [GO] 2023―Feb―16 Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine Danping Zhao, Xiuhong Chen, Linyuan Wang, Jianjun Zhang, Zhongpeng Zhao, Na Yue, et al. (+5)
66 [GO] 2023―Feb―03 Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (Mpro) by using STD-NMR spectroscopy, in silico studies and antiviral assays A. Mateen Khan, Saba Farooq, M. Iqbal Choudhary
67 [GO] 2023―Jan―20 Identification and characterization of aurintricarboxylic acid as a potential inhibitor of SARS-CoV-2 PLpro Rimanshee Arya, Vishal Prashar, Mukesh Kumar
68 [GO] 2023―Jan―09 Proteomic screening identifies RPLp2 as a specific regulator for the translation of coronavirus Hui-Jun Dong, Jing Wang, Xiu-Zhong Zhang, Cui-Cui Li, Jian-Feng Liu, Xiao-Jia Wang
69 [GO] 2022―Dec―30 Inhibitory effects of fucoidan from Laminaria japonica against some pathogenic bacteria and SARS-CoV-2 depend on its large molecular weight Xiaona Sun, Chunqing Ai, Chengrong Wen, Haoran Peng, Jingfeng Yang, Yuna Cui, Shuang Song
70 [GO] 2022―Dec―29 Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update Manojit Bhattacharya, Srijan Chatterjee, Sang-Soo Lee, Chiranjib Chakraborty
71 [GO] 2022―Dec―28 Major royal jelly proteins elicited suppression of SARS-CoV-2 entry and replication with halting lung injury Marwa M. Abu-Serie, Noha H. Habashy
72 [GO] 2022―Dec―14 SARS-CoV-2 RdRp uses NDPs as a substrate and is able to incorporate NHC into RNA from diphosphate form molnupiravir Maofeng Wang, Cancan Wu, Nan Liu, Fengyu Zhang, Hongjie Dong, Shuai Wang, et al. (+4)
73 [GO] 2022―Dec―14 Human antibody BD-218 has broad neutralizing activity against concerning variants of SARS-CoV-2 Bo Wang, Hua Xu, Zi-teng Liang, Tian-ning Zhao, Xin Zhang, Tian-bo Peng, et al. (+2)
74 [GO] 2022―Dec―14 Non-anticoagulant heparin derivatives for COVID-19 treatment Min Cao, Meng Qiao, Muhammad Sohail, Xing Zhang
75 [GO] 2022―Dec―12 Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay Yusen Xiang, Guanglei Zhai, Yaozong Li, Mengge Wang, Xixiang Chen, Ruyu Wang, et al. (+9)
76 [GO] 2022―Dec―05 Inhibitory activities of alginate phosphate and sulfate derivatives against SARS-CoV-2 in vitro Cheng Yang, Dan Li, Shixin Wang, Meijie Xu, Dingfu Wang, Xin Li, et al. (+2)
77 [GO] 2022―Nov―24 Structural evolution of Delta lineage of SARS-CoV-2 Mohammad Mahmoudi Gomari, Parastoo Tarighi, Edris Choupani, Shadi Abkhiz, Masoud Mohamadzadeh, Neda Rostami, et al. (+4)
78 [GO] 2022―Oct―08 Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity Mario Cano-Muñoz, Daniel Polo-Megías, Ana Cámara-Artigas, José A. Gavira, María J. López-Rodríguez, Géraldine Laumond, et al. (+5)
79 [GO] 2022―Oct―05 The inhibitory activity of methoxyl flavonoids derived from Inula britannica flowers on SARS-CoV-2 3CLpro Jang Hoon Kim, Yea-In Park, Mok Hur, Woo Tae Park, Youn-Ho Moon, Sung-Cheol Koo, et al. (+2)
80 [GO] 2022―Sep―29 Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases Otávio Augusto Chaves, Carlyle Ribeiro Lima, Natalia Fintelman-Rodrigues, Carolina Q. Sacramento, Caroline S. de Freitas, Leonardo Vazquez, et al. (+7)
81 [GO] 2022―Sep―26 Non-uniform aspects of the SARS-CoV-2 intraspecies evolution reopen question of its origin Sk. Sarif Hassan, Vaishnavi Kodakandla, Elrashdy M. Redwan, Kenneth Lundstrom, Pabitra Pal Choudhury, Ángel Serrano-Aroca, et al. (+15)
82 [GO] 2022―Sep―22 Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance Hanieh Shirvani, Hanieh Jafari, Sayyed Sajjad Moravveji, Fatemeh Abbasi Faranghizadeh, Mehrdad Talebi, Jalaledin Ghanavi, et al. (+5)
83 [GO] 2022―Sep―21 A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan Yunxia He, Weili Yu, Lijuan Shen, Wenying Yan, Lucheng Xiao, Jinming Qi, Tao Hu
84 [GO] 2022―Sep―18 Recent advances in applying G-quadruplex for SARS-CoV-2 targeting and diagnosis: A review Li-Yan Zhai, Ai-Min Su, Jing-Fan Liu, Jian-Jin Zhao, Xu-Guang Xi, Xi-Miao Hou
85 [GO] 2022―Sep―03 Unfolding of the SARS-CoV-2 spike protein through infrared and ultraviolet-C radiation based disinfection Nilkamal Mahanta, Swati Sharma, Laipubam Gayatri Sharma, Lalit M. Pandey, Uday Shanker Dixit
86 [GO] 2022―Jul―28 The SARS-CoV-2 targeted human RNA binding proteins network biology to investigate COVID-19 associated manifestations Kartikay Prasad, Pratibha Gour, Saurabh Raghuvanshi, Vijay Kumar
87 [GO] 2022―Jul―13 An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD) Dwipanjan Sanyal, Suharto Banerjee, Aritra Bej, Vaidehi Roy Chowdhury, Vladimir N. Uversky, Sourav Chowdhury, Krishnananda Chattopadhyay
88 [GO] 2022―Jun―08 Production and characterization of chimeric SARS-CoV-2 antigens based on the capsid protein of cowpea chlorotic mottle virus Claudia Almendárez-Rodriguez, Karla I. Solis-Andrade, Dania O. Govea-Alonso, Mauricio Comas-Garcia, Sergio Rosales-Mendoza
89 [GO] 2022―Apr―23 Designing and characterization of a SARS-CoV-2 immunogen with receptor binding motif grafted on a protein scaffold: An epitope-focused vaccine approach Ritika Khatri, Hilal Ahmad Parray, Ashish Kumar Agrahari, Zaigham Abbas Rizvi, Rachel Kaul, Sneha Raj, et al. (+5)
90 [GO] 2022―Apr―20 Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2 Tingting Li, Bingjie Zhou, Yaning Li, Suqiong Huang, Zhipu Luo, Yuanze Zhou, et al. (+8)
91 [GO] 2022―Apr―19 Expression, purification, and biophysical characterization of recombinant MERS-CoV main (Mpro) protease Ghada Obeid Almutairi, Ajamaluddin Malik, Mona Alonazi, Javed Masood Khan, Abdullah S. Alhomida, Mohd Shahnawaz Khan, et al. (+3)
92 [GO] 2022―Mar―26 Interfering effects on the bioactivities of several key proteins of COVID-19/variants in diabetes by compounds from Lianqiao leaves: In silico and in vitro analyses Yishan Fu, Fei Pan, Lei Zhao, Shuai Zhao, Junjie Yi, Shengbao Cai
93 [GO] 2022―Mar―16 An insight to the therapeutic potential of algae-derived sulfated polysaccharides and polyunsaturated fatty acids: Focusing on the COVID-19 Kobra Ziyaei, Zahra Ataie, Majid Mokhtari, Kelvin Adrah, Mohammad Ali Daneshmehr
94 [GO] 2022―Mar―15 The spike glycoproteins of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape Pedro F.N. Souza, Felipe P. Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny R.P. Lima, Marília B. Costa, et al. (+8)
95 [GO] 2022―Feb―08 Human SARS-CoV-2 has evolved to increase U content and reduce genome size Yong Wang, Xin-Yu Chen, Liu Yang, Qin Yao, K.P. Chen
96 [GO] 2022―Jan―22 Three wave changes, new variant strains, and vaccination effect against COVID-19 pandemic Rehan M. El-Shabasy, Mohamed A. Nayel, Mohamed M. Taher, Rehab Abdelmonem, Kamel R. Shoueir, El Refaie Kenawy
97 [GO] 2022―Jan―22 Insights into the specificity for the interaction of the promiscuous SARS-CoV-2 nucleocapsid protein N-terminal domain with deoxyribonucleic acids Icaro Putinhon Caruso, Vitor dos Santos Almeida, Mariana Juliani do Amaral, Guilherme Caldas de Andrade, Gabriela Rocha de Araújo, Talita Stelling de Araújo, et al. (+21)
98 [GO] 2022―Jan―20 Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic Wan Lu, Zhuangzhuang Zhao, Yao-Wei Huang, Bin Wang
99 [GO] 2022―Jan―19 The Omicron (B.1.1.529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: Insights from structural and simulation data Abbas Khan, Hira Waris, Memoona Rafique, Muhammad Suleman, Anwar Mohammad, Syed Shujait Ali, et al. (+4)
100 [GO] 2022―Jan―17 Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19 Wajihul Hasan Khan, Nida Khan, Avinash Mishra, Surbhi Gupta, Vikrant Bansode, Deepa Mehta, et al. (+4)
101 [GO] 2021―Dec―28 Silymarin/curcumin loaded albumin nanoparticles coated by chitosan as muco-inhalable delivery system observing anti-inflammatory and anti COVID-19 characterizations in oleic acid triggered lung injury and in vitro COVID-19 experiment Nemany A.N. Hanafy, Maged A. El-Kemary
102 [GO] 2021―Dec―23 Is amyloid fibrillation related to 3D domain swapping for the C-terminal domain of SARS-CoV main protease? Zhiliang Yuan, Zhi Qu, Bo Duan, Tianyi Wang, Jiajun Xu, Bin Xia
103 [GO] 2021―Dec―04 Precise location of two novel linear epitopes on the receptor-binding domain surface of MERS-CoV spike protein recognized by two different monoclonal antibodies Pan Wang, Peiyang Ding, Qiang Wei, Aiping Wang, Hongliang Liu, Yunchao Liu, et al. (+5)
104 [GO] 2021―Dec―02 Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function Sk. Sarif Hassan, Kenneth Lundstrom, Ángel Serrano-Aroca, Parise Adadi, Alaa A.A. Aljabali, Elrashdy M. Redwan, et al. (+13)
105 [GO] 2021―Nov―24 Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome Salem A. El-aarag, Amal Mahmoud, Mahmoud ElHefnawi
106 [GO] 2021―Nov―12 COVID-19 diagnosis: current and future techniques Aarjoo Sharma, Sanjeev Balda, Mansi Apreja, Kirti Kataria, Neena Capalash, Prince Sharma
107 [GO] 2021―Nov―11 Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice Hui-Tsu Lin, Cheng-cheung Chen, Der-Jiang Chiao, Tein-Yao Chang, Xin-an Chen, Jenn-jong Young, Szu-Cheng Kuo
108 [GO] 2021―Nov―11 Structural and functional significance of the amino acid differences Val35Thr, Ser46Ala, Asn65Ser, and Ala94Ser in 3C-like proteinases from SARS-CoV-2 and SARS-CoV Alexander I. Denesyuk, Eugene A. Permyakov, Mark S. Johnson, Sergei E. Permyakov, Konstantin Denessiouk, Vladimir N. Uversky
109 [GO] 2021―Oct―31 Immunology and controlling of coronaviruses; the current enemy for humanity: A review Sarah I. Othman, Mohamed A. Nayel, Maha Abdulla Alwaele, Haifa Al Fassam, Gasem Mohammad Abu-Taweel, Naif Ghazi Altoom, et al. (+4)
110 [GO] 2021―Oct―29 SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate Yi Zheng, Jinxiang Zhao, Jiaqi Li, Zhimou Guo, Jiajing Sheng, Xianlong Ye, et al. (+6)
111 [GO] 2021―Oct―28 SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review Jahangir Emrani, Maryam Ahmed, Robert H. Newman, Misty D. Thomas, Nathan Mowa, Liesl JeffersFrancis, John C. Teleha
112 [GO] 2021―Oct―25 COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks Chandran Murugan, Sharmiladevi Ramamoorthy, Kuppuswamy Guruprasad, Rajesh Kumar Murugan, Yuvaraj Sivalingam, Anandhakumar Sundaramurthy
113 [GO] 2021―Oct―18 Review: Roles of human serum albumin in prediction, diagnoses and treatment of COVID-19 Gulam Rabbani, Saeyoung Nate Ahn
114 [GO] 2021―Oct―15 State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis? Bhargab Kalita, Anthony J. Saviola, Stephen P. Samuel, Ashis K. Mukherjee
115 [GO] 2021―Sep―27 Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2 Sushil Pokhrel, Thamer A. Bouback, Abdus Samad, Suza Mohammad Nur, Rahat Alam, Md. Abdullah-Al-Mamun, et al. (+9)
116 [GO] 2021―Sep―24 Implications derived from S-protein variants of SARS-CoV-2 from six continents Sk. Sarif Hassan, Kenneth Lundstrom, Debmalya Barh, Raner Jośe Santana Silva, Bruno Silva Andrade, Vasco Azevedo, et al. (+18)
117 [GO] 2021―Sep―10 Genomics-guided targeting of stress granule proteins G3BP1/2 to inhibit SARS-CoV-2 propagation Nemat Ali, Kartikay Prasad, Abdullah F. AlAsmari, Metab Alharbi, Summya Rashid, Vijay Kumar
118 [GO] 2021―Sep―07 Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2 Letian Li, Maopeng Wang, Jiayi Hao, Jicheng Han, Tingting Fu, Jieying Bai, et al. (+4)
119 [GO] 2021―Aug―18 Review on oxidative stress relation on COVID-19: Biomolecular and bioanalytical approach Mehrnaz Ebrahimi, Parviz Norouzi, Hossein Aazami, Ali Akbar Moosavi-Movahedi
120 [GO] 2021―Aug―14 SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review Hadis Fathizadeh, Saman Afshar, Mahmood Reza Masoudi, Pourya Gholizadeh, Mohammad Asgharzadeh, Khudaverdi Ganbarov, et al. (+3)
121 [GO] 2021―Aug―06 Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease Yunxia Xu, Ke Chen, Juanli Pan, Yingshou Lei, Danting Zhang, Lipei Fang, et al. (+8)
122 [GO] 2021―Aug―06 The method utilized to purify the SARS-CoV-2 N protein can affect its molecular properties Aneta Tarczewska, Marta Kolonko-Adamska, Mirosław Zarębski, Jurek Dobrucki, Andrzej Ożyhar, Beata Greb-Markiewicz
123 [GO] 2021―Jul―30 Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms Yuan Xiong, Guang-Hao Zhu, Ya-Ni Zhang, Qing Hu, Hao-Nan Wang, Hao-Nan Yu, et al. (+5)
124 [GO] 2021―Jul―27 Chitosan derivatives: A suggestive evaluation for novel inhibitor discovery against wild type and variants of SARS-CoV-2 virus Chandrima Modak, Anubhuti Jha, Nivya Sharma, Awanish Kumar
125 [GO] 2021―Jul―05 Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2 Pravas Kumar Baral, Jiang Yin, Michael N.G. James
126 [GO] 2021―Jun―07 A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2) Mao-Sen Zeng, Wen-Di Yu, Hui-Xian Wang, Jin-Yuan Liu, Pei-Ping Xu
127 [GO] 2021―May―26 Ethyl cellulose coated sustained release aspirin spherules for treating COVID-19: DOE led rapid optimization using arbitrary interface; applicable for emergency situations T. Sreejith, Kaladhar Kamalasanan, Ashna Moidu, Pooja Shyamsundar, Shanti V. Nair, Lakshmi J. Nair, P. Venkatesan
128 [GO] 2021―May―25 Chitosan, alginate, hyaluronic acid, gums, and β-glucan as potent adjuvants and vaccine delivery systems for viral threats including SARS-CoV-2: A review Shadpour Mallakpour, Elham Azadi, Chaudhery Mustansar Hussain
129 [GO] 2021―Apr―27 Chitin and chitosan as tools to combat COVID-19: A triple approach Mehrnoush Safarzadeh, Sahar Sadeghi, Mahdieh Azizi, Mohsen Rastegari-Pouyani, Ramin Pouriran, Mostafa Haji Molla Hoseini
130 [GO] 2021―Apr―26 Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy Yash Gupta, Dawid Maciorowski, Samantha E. Zak, Chandrashekhar V. Kulkarni, Andrew S. Herbert, Ravi Durvasula, et al. (+3)
131 [GO] 2021―Apr―24 Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro Ruyu Wang, Qing Hu, Haonan Wang, Guanghao Zhu, Mengge Wang, Qian Zhang, et al. (+6)
132 [GO] 2021―Apr―21 Preparation of cellulose based wipes treated with antimicrobial and antiviral silver nanoparticles as novel effective high-performance coronavirus fighter Tamer Hamouda, Hassan M. Ibrahim, H.H. Kafafy, H.M. Mashaly, Nasser H. Mohamed, Nermin M. Aly
133 [GO] 2021―Apr―16 Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2 Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Vladimir N. Uversky, Alaa A.A. Aljabali, et al. (+19)
134 [GO] 2021―Mar―29 A review on antiviral and immunomodulatory polysaccharides from Indian medicinal plants, which may be beneficial to COVID-19 infected patients Ipsita Kumar Sen, Indranil Chakraborty, Amit Kumar Mandal, Sunil Kumar Bhanja, Sukesh Patra, Prasenjit Maity
135 [GO] 2021―Mar―23 A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase Suliman Khan, Farnoosh Attar, Samir Haj Bloukh, Majid Sharifi, Faisal Nabi, Qian Bai, et al. (+2)
136 [GO] 2021―Mar―12 Exploitation of polyphenols and proteins using nanoencapsulation for anti-viral and brain boosting properties - Evoking a synergistic strategy to combat COVID-19 pandemic Nairah Noor, Adil Gani, Asir Gani, Asima Shah, Zanoor ul Ashraf
137 [GO] 2021―Mar―02 The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play Pedro F.N. Souza, Felipe P. Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny R.P. Lima, Marília B. Costa, et al. (+3)
138 [GO] 2021―Mar―01 SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development Mandeep Kaur, Akanksha Sharma, Santosh Kumar, Gurpal Singh, Ravi P. Barnwal
139 [GO] 2021―Feb―17 Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2? Nivya Sharma, Chandrima Modak, Pankaj Kumar Singh, Rahul Kumar, Dharmender Khatri, Shashi Bala Singh
140 [GO] 2021―Feb―11 COVID-19 as a worldwide selective event and bitter taste receptor polymorphisms: An ecological correlational study Shima Parsa, Vahid Mogharab, Mohsen Ebrahimi, Sayyed Reza Ahmadi, Behzad Shahi, Neema John Mehramiz, et al. (+7)
141 [GO] 2021―Feb―09 Potential drug targets of SARS-CoV-2: From genomics to therapeutics Anas Shamsi, Taj Mohammad, Saleha Anwar, Samreen Amani, Mohd Shahnawaz Khan, Fohad Mabood Husain, et al. (+3)
142 [GO] 2021―Feb―05 Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2 Ashuai Du, Rong Zheng, Cyrollah Disoma, Shiqin Li, Zongpeng Chen, Sijia Li, et al. (+18)
143 [GO] 2021―Feb―05 Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein Shruti Mukherjee, Amaravadhi Harikishore, Anirban Bhunia
144 [GO] 2021―Jan―11 SARS-Cov-2 ORF3a: Mutability and function Martina Bianchi, Alessandra Borsetti, Massimo Ciccozzi, Stefano Pascarella
145 [GO] 2020―Dec―29 Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study Shreya Bhattacharya, Arundhati Banerjee, Sujay Ray
146 [GO] 2020―Dec―09 Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs Naveen Narayanan, Deepak T. Nair
147 [GO] 2020―Dec―06 Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches Vinit Raj, Jae Gyu Park, Kiu-Hyung Cho, Pilju Choi, Taejung Kim, Jungyeob Ham, Jintae Lee
148 [GO] 2020―Sep―28 Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials Fatemeh Oroojalian, Ali Haghbin, Behzad Baradaran, Nima Hemmat, Mohammad-Ali Shahbazi, Hossein Bannazadeh Baghi, et al. (+2)
149 [GO] 2020―Sep―24 Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13) Osman Mutluhan Ugurel, Ozal Mutlu, Emrah Sariyer, Sinem Kocer, Erennur Ugurel, Tugba Gul Inci, et al. (+2)
150 [GO] 2020―Sep―24 The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica Weihua Jin, Wenjing Zhang, Dipanwita Mitra, Martin G. McCandless, Poonam Sharma, Ritesh Tandon, et al. (+2)
151 [GO] 2020―Sep―17 Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach Md. Sorwer Alam Parvez, Md. Adnan Karim, Mahmudul Hasan, Jomana Jaman, Ziaul Karim, Tohura Tahsin, et al. (+2)
152 [GO] 2020―Aug―24 Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2 Praveen Kumar Tripathi, Saurabh Upadhyay, Manju Singh, Siva Raghavendhar, Mohit Bhardwaj, Pradeep Sharma, Ashok Kumar Patel
153 [GO] 2020―Aug―01 Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening Olga Abian, David Ortega-Alarcon, Ana Jimenez-Alesanco, Laura Ceballos-Laita, Sonia Vega, Hugh T. Reyburn, et al. (+2)
154 [GO] 2020―Jul―18 A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor Pedro F.N. Souza, Francisco E.S. Lopes, Jackson L. Amaral, Cleverson D.T. Freitas, Jose T.A. Oliveira
155 [GO] 2020―Jul―15 Design of a Multi-epitope Vaccine against SARS-CoV-2 using Immunoinformatics approach Samira Sanami, Milad Zandi, Behzad Pourhossein, Gholam-Reza Mobini, Mohsen Safaei, Atena Abed, et al. (+3)
156 [GO] 2020―Jul―14 Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines Xiangyan Chen, Wenwei Han, Guixiang Wang, Xia Zhao
157 [GO] 2020―Jun―26 Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective Kartikay Prasad, Fatima Khatoon, Summya Rashid, Nemat Ali, Abdullah F. AlAsmari, Mohammad Z. Ahmed, et al. (+3)
158 [GO] 2020―Jun―26 Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach Ishtiaque Ahammad, Samia Sultana Lira
159 [GO] 2020―May―30 A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2 Maopeng Wang, Tingting Fu, Jiayi Hao, Letian Li, Mingyao Tian, Ningyi Jin, et al. (+2)
160 [GO] 2020―May―26 High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment Biswajit Naik, Nidhi Gupta, Rupal Ojha, Satyendra Singh, Vijay Kumar Prajapati, Dhaneswar Prusty
161 [GO] 2019―Dec―02 Construction and optimization of Lactobacillus plantarum expression system expressing glycoprotein 5 of porcine reproductive and respiratory syndrome virus Maopeng Wang, Shouwen Du, Wang Xu, Lina Song, Pengfei Hao, Ningyi Jin, et al. (+2)
 [1] 

161 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec